Medirom Healthcare Technologies (NASDAQ:MRM) Shares Down 8.4% – Time to Sell?

Shares of Medirom Healthcare Technologies Inc. (NASDAQ:MRMGet Free Report) were down 8.4% during trading on Thursday . The stock traded as low as $1.50 and last traded at $1.53. Approximately 65,198 shares traded hands during trading, a decline of 64% from the average daily volume of 182,452 shares. The stock had previously closed at $1.67.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings reissued a “sell (d+)” rating on shares of Medirom Healthcare Technologies in a research note on Monday, December 29th. One research analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the company presently has an average rating of “Sell”.

Get Our Latest Stock Report on Medirom Healthcare Technologies

Medirom Healthcare Technologies Price Performance

The company has a quick ratio of 0.21, a current ratio of 0.24 and a debt-to-equity ratio of 2.42.

Medirom Healthcare Technologies (NASDAQ:MRMGet Free Report) last issued its earnings results on Tuesday, October 21st. The company reported ($0.30) EPS for the quarter. The business had revenue of $11.28 million for the quarter.

About Medirom Healthcare Technologies

(Get Free Report)

MEDIROM Healthcare Technologies Inc provides holistic healthcare services in Japan. It operates in two segments, Relaxation Salon and Digital Preventative Healthcare. The Relaxation Salon segment owns and franchises relaxation salons, which provide finger-pressure style bodywork therapy, stretch therapy, and posture and joint alignment, as well as physical therapy elements; and various individual services, including anti-fatigue therapy, athletic support therapy, slim-down therapy, and reflexology.

Read More

Receive News & Ratings for Medirom Healthcare Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medirom Healthcare Technologies and related companies with MarketBeat.com's FREE daily email newsletter.